Incyte
INCY
#1110
Rank
HK$156.68 B
Marketcap
HK$798.08
Share price
2.05%
Change (1 day)
36.89%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$13.07 Billion

According to Incyte's latest financial reports the company's total liabilities are HK$13.07 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$15.50 B24.65%
2023-12-31HK$12.43 B8.21%
2022-12-31HK$11.49 B26.69%
2021-12-31HK$9.07 B23.22%
2020-12-31HK$7.36 B14.12%
2019-12-31HK$6.45 B14.45%
2018-12-31HK$5.63 B7.37%
2017-12-31HK$5.24 B-44.47%
2016-12-31HK$9.45 B45.85%
2015-12-31HK$6.48 B-4.83%
2014-12-31HK$6.81 B6.77%
2013-12-31HK$6.37 B62.85%
2012-12-31HK$3.91 B-9.3%
2011-12-31HK$4.31 B-4.03%
2010-12-31HK$4.49 B-28.77%
2009-12-31HK$6.31 B80.42%
2008-12-31HK$3.50 B3.19%
2007-12-31HK$3.39 B-0.5%
2006-12-31HK$3.41 B11.79%
2005-12-31HK$3.05 B-10.45%
2004-12-31HK$3.40 B95.16%
2003-12-31HK$1.74 B-10.36%
2002-12-31HK$1.94 B-5.88%
2001-12-31HK$2.06 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
HK$626.83 B 4,695.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$4.09 B-68.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$709.05 B 5,324.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$900.17 B 6,786.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
HK$2.48 B-81.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$2.58 B-80.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.82 B 3,624.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
HK$0.56 B-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
HK$1.07 B-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA